Australian & New Zealand Mental Health Association Australian & New Zealand Addiction Conference 2023

Australian & New Zealand Mental Health Association Australian & New Zealand Addiction Conference 2023

Include: 2 videos, size: 51.55 GB
Target Audience: addiction clinicians, psychiatrists
Information:

A practical, cross-disciplinary meeting focused on prevention, treatment, and recovery across alcohol, tobacco, and other drugs (ATOD). Sessions blend evidence, policy, and lived-experience perspectives to translate research into services that work in real settings.

What You Will Learn

• Current best practices for screening, brief intervention, and referral to treatment (SBIRT)

• Evidence-based care for alcohol, opioids, stimulants, cannabis, and polysubstance use

• Harm-reduction strategies, overdose prevention, and post-overdose engagement

• Co-occurring mental health, trauma, and physical health management

• Culturally safe, youth-friendly, and justice-informed approaches

• Service design: integrated care, digital health, measurement, and quality improvement

Event Details

• Features: Practice toolkits, service case studies, and lived-experience forums

• Focus: Translating evidence into policy and frontline implementation across Australia & New Zealand

Who Should Attend
Addiction clinicians, psychiatrists, psychologists, GPs, nurses, social workers, peer workers, public health leaders, NGO and government program managers, researchers, educators, policymakers, and students.

Why Attend

• Turn guidelines into practical pathways you can deploy in clinics, communities, and systems

• Learn what’s working in real programs—outcomes, pitfalls, and scalability

• Build partnerships across health, community, and justice to improve access and equity

Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

Apr 27.mp4

Apr 28.mp4

*Detail:

• Alcohol, opioids, stimulants, cannabis, vaping, and emerging substances

• Harm reduction: naloxone, needle/syringe programs, supervised consumption, safer-use education

• Co-occurring conditions: depression, anxiety, PTSD, psychosis, pain, infectious diseases

• Youth, perinatal, First Nations and Māori/Pasifika-led models of care

• Justice, homelessness, and rural/remote service delivery

• Digital tools, telehealth, data, and outcome measurement

• Workforce wellbeing, supervision, ethics, and lived-experience leadership